Published in J Bone Oncol on July 08, 2016
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 13.15
Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer (2002) 12.45
Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer (2004) 9.68
Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res (2006) 7.83
MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A (2008) 5.15
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest (2011) 4.43
Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res (2010) 4.15
To differentiate or not--routes towards metastasis. Nat Rev Cancer (2012) 3.59
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet (2010) 3.12
Preparing the "soil": the premetastatic niche. Cancer Res (2006) 2.92
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature (2014) 2.63
miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature (2014) 2.26
Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res (2010) 1.95
MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov (2012) 1.75
MicroRNAs associated with metastatic prostate cancer. PLoS One (2011) 1.66
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal (2014) 1.62
Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell (2013) 1.62
miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem (2012) 1.39
miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep (2012) 1.29
miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev (2013) 1.19
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene (2013) 1.19
OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One (2013) 1.09
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease. Cancer Res (2015) 1.09
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology (2014) 1.08
Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget (2015) 1.07
Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer. Int J Oncol (2014) 1.07
The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. Biomaterials (2013) 1.05
Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia (2011) 1.04
Collective cell migration: guidance principles and hierarchies. Trends Cell Biol (2015) 1.04
miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression. Cancer Res (2015) 0.99
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacol Res (2015) 0.98
MicroRNAs in the control of metastatic bone disease. Trends Endocrinol Metab (2014) 0.92
Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT. J Oncol (2015) 0.91
MiR-26a inhibits prostate cancer progression by repression of Wnt5a. Tumour Biol (2014) 0.90
A microRNA code for prostate cancer metastasis. Oncogene (2015) 0.89
The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches. PLoS One (2014) 0.89
Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture. Prostate (2005) 0.87
Are RNAi and miRNA therapeutics truly dead? Trends Biotechnol (2015) 0.86
miR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression. Bone (2012) 0.85
The role of microRNAs in bone remodeling. Int J Oral Sci (2015) 0.84
MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer. Int J Clin Exp Pathol (2015) 0.84
Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res (2014) 0.84
Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Oncotarget (2016) 0.84
MicroRNA-183 increases osteoclastogenesis by repressing heme oxygenase-1. Bone (2015) 0.83
Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror. Cancer Cell (2013) 0.82
Biology of Bone Metastases in Prostate Cancer. Urology (2016) 0.82
MicroRNAs as regulators of tumor-associated stromal cells. Oncotarget (2013) 0.80
Extracellular Vesicles and Their Role in Urologic Malignancies. Eur Urol (2016) 0.77